Marshall Wace North America’s Patterson-UTI PTEN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q2
– Sell
-274,932
Closed -$646K – 1413
2020
Q1
$646K Buy
+274,932
New +$1.78M ﹤0.01% 704
2019
Q4
– Sell
-36,667
Closed -$313K – 1540
2019
Q3
$313K Sell
36,667
-866,161
-96% -$8.49M ﹤0.01% 883
2019
Q2
$10.4M Buy
902,828
+516,611
+134% +$6.65M 0.06% 234
2019
Q1
$5.42M Buy
386,217
+226,795
+142% +$2.97M 0.04% 314
2018
Q4
$1.65M Buy
159,422
+68,651
+76% +$1.01M 0.02% 474
2018
Q3
$1.55M Sell
90,771
-154,982
-63% -$2.66M 0.01% 537
2018
Q2
$4.42M Sell
245,753
-302,755
-55% -$6.07M 0.03% 546
2018
Q1
$9.6M Sell
548,508
-268,804
-33% -$5.61M 0.05% 405
2017
Q4
$18.8M Sell
817,312
-684,566
-46% -$14.2M 0.1% 238
2017
Q3
$31.5M Buy
1,501,878
+374,434
+33% +$6.9M 0.2% 137
2017
Q2
$22.5M Buy
1,127,444
+757,798
+205% +$16.5M 0.16% 161
2017
Q1
$8.87M Buy
+369,646
New +$9.97M 0.07% 295
2013
Q4
– Sell
-621,095
Closed -$13.3M – 813
2013
Q3
$13.3M Buy
621,095
+337,320
+119% +$6.93M 0.41% 71
2013
Q2
$5.49M Buy
+283,775
New +$6.19M 0.43% 84

Other funds holding PTEN

Marshall Wace North America's PTEN Position: Q2 2020 in Review

Marshall Wace North America sold out of Patterson-UTI (PTEN) in Q2 2020, closing a stake of 274,932 shares — an estimated $646K sold.

Marshall Wace North America first reported a position in PTEN in Q2 2013 and held it in 14 quarters. The position peaked at $31.5M in Q3 2017. 233 funds tracked by Wall St. Rank hold PTEN as of Q2 2020.

  • Marshall Wace North America reported no remaining Patterson-UTI position as of Q2 2020 after selling out during the quarter.
  • Marshall Wace North America sold 274,932 Patterson-UTI shares in Q2 2020, an estimated $646K.
  • Marshall Wace North America first reported a position in Patterson-UTI in Q2 2013 and held it in 14 quarters.
  • Marshall Wace North America's Patterson-UTI position peaked at $31.5M in Q3 2017.
  • 233 funds tracked by Wall St. Rank held Patterson-UTI as of Q2 2020.

Based on Marshall Wace North America's 13F filing for Q2 2020, filed 13 Aug 2020.